Assessment of dermal irritation is an essential component of the safety evaluation of medical devices. Reconstructed human epidermis (RhE) models have replaced rabbit skin irritation testing for neat chemicals (OECD TG 439). However, medical device (MD) extracts are dilute solutions with low irritation potential, therefore the validated RhE-methods needed to be modified to reflect needs of ISO 10993.
A protocol employing RhE EpiDerm was optimized in 2013 using known irritants and spiked polymers (Casas et al., TIV, 2013). In 2014 a second laboratory assessed the transferability of the assay. After the successful transfer and standardization of the protocol, 17 laboratories worldwide were trained in the use of the protocol in the preparation for the validation. All laboratories produced data with almost 100% agreement of predictions for the selected references.
In 2016, an international round robin validation study was conducted to confirm the ability of the RhE models to correctly predict the intra-cutaneous irritation of extracts from MDs. Four irritant polymers and three non-irritant controls were tested. Blinded polymer samples were extracted with sesame oil and saline per ISO 10993-12. Positive and negative solvent controls were included.
The EpiDerm tissues were able to correctly identify virtually all of the irritant polymer samples either in the saline or in the sesame oil or in both solvent extracts. Our results indicate that RhE tissue models can detect the presence of skin irritants at low concentrations in dilute medical device polymer extracts. The use of the reconstructed tissue models, as replacements for the rabbit intra-cutaneus test if being implemented into the ISO 10993 standards used to evaluate medical device biocompatibility. The work will be published in a special issue of Toxicology in Vitro in 2018.
